Lymphatic malformations: Current cellular and clinical investigations

Otolaryngology - Head and Neck Surgery

Volumn 142, Issue 6, 2010, Pages 789-794

  Perkins, Jonathan A ^a,b   Manning, Scott C ^a,b   Tempero, Richard M ^c   Cunningham, Michael J ^d   Edmonds Jr , Joseph L ^e,g,h,i   Hoffer, Fredric A ^f   Egbert, Mark A ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^d MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^e Children's ENT of Houston   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; DEVELOPMENT; DISEASE MODEL; ENDOTHELIUM CELL; EVIDENCE BASED MEDICINE; HEAD AND NECK MALFORMATION; HEAD AND NECK SURGERY; HEALTH CARE COST; HUMAN; LYMPHATIC MALFORMATION; LYMPHATIC SYSTEM; MEDICAL RESEARCH; NECK DISSECTION; NONHUMAN; PAROTIDECTOMY; PATHOGENESIS; SCLEROTHERAPY; STROMA CELL; TONSILLECTOMY;

ANIMALS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHANGIOGENESIS; LYMPHANGIOMA, CYSTIC; LYMPHATIC VESSELS; MODELS, ANIMAL; TREATMENT OUTCOME; VASCULAR MALFORMATIONS;

EID: 77952244541     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2010.02.025     Document Type: Article

References (32)

1. Mulliken J.B., and Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69 (1982) 412-422
2. North P.E., Waner M., Mizeracki A., et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31 (2000) 11-22
3. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
4. Petrova T.V., Karpanen T., Norrmen C., et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10 (2004) 974-981
5. Irrthum A., Karkkainen M.J., Devriendt K., et al. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67 (2000) 295-301
6. Sabin F.R. The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. Am J Anat 9 (1909) 43-91
7. Wigle J.T., and Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 98 (1999) 769-778
8. Adams R.H., Diella F., Hennig S., et al. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell 104 (2001) 57-69
9. Baluk P., Tammela T., Ator E., et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115 (2005) 247-257
10. Tobler N.E., and Detmar M. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis. J Leukoc Biol 80 (2006) 691-696
11. Hirakawa S., Brown L.F., Kodama S., et al. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109 (2007) 1010-1017
12. D'Alton M., and Cleary-Goldman J. First and second trimester evaluation of risk for fetal aneuploidy: the secondary outcomes of the FASTER trial. Semin Perinatol 29 (2005) 240-246
13. Gedikbasi A., Gul A., Sargin A., et al. Cystic hygroma and lymphangioma: associated findings, perinatal outcome and prognostic factors in live-born infants. Arch Gynecol Obstet 276 (2007) 491-498
14. Norgall S., Papoutsi M., Rossler J., et al. Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. BMC Cancer 7 (2007) 105
15. Huang H.Y., Ho C.C., Huang P.H., et al. Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma. Lab Invest 81 (2001) 1729-1734
16. Partanen T.A., Alitalo K., and Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86 (1999) 2406-2412
17. Chen E.Y., Hostikka S.L., Oliaei S., et al. Similar histologic features and immunohistochemical staining in microcystic and macrocystic lymphatic malformations. Lymphat Res Biol 7 (2009) 75-80
18. Fleming J.N., Hostikka S.L., Chen E.Y., et al. Plasmacytoid dendritic cells and interferon levels are increased in lymphatic malformations. Otolaryngol Head Neck Surg 139 (2008) 671-676
19. de Serres L.M., Sie K.C., and Richardson M.A. Lymphatic malformations of the head and neck. A proposal for staging. Arch Otolaryngol Head Neck Surg 121 (1995) 577-582
20. Riechelmann H., Muehlfay G., Keck T., et al. Total, subtotal, and partial surgical removal of cervicofacial lymphangiomas. Arch Otolaryngol Head Neck Surg 125 (1999) 643-648
21. Enjolras O. Vascular tumors and vascular malformations: are we at the dawn of a better knowledge?. Pediatr Dermatol 16 (1999) 238-241
22. Giguere C.M., Bauman N.M., Sato Y., et al. Treatment of lymphangiomas with OK-432 (picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg 128 (2002) 1137-1144
23. Burrows P.E., and Mason K.P. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 15 (2004) 431-445
24. Kennedy T.L., Whitaker M., Pellitteri P., et al. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope 111 (2001) 1929-1937
25. Birkmeyer J.D. Outcomes research and surgeons. Surgery 124 (1998) 477-483
26. Gerszten P.C. Outcomes research: a review. Neurosurgery 43 (1998) 1146-1156
27. Epstein R.S. Responsiveness in quality-of-life assessment: nomenclature, determinants, and clinical applications. Med Care 38 (2000) 1191-1194
28. Harsha W.J., Perkins J.A., Lewis C.W., et al. Pediatric admissions and procedures for lymphatic malformations in the United States: 1997 and 2000. Lymphat Res Biol 3 (2005) 58-65
29. Griebsch I., Coast J., and Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics 115 (2005) e600-e614
30. Fischer D., Stewart A.L., Bloch D.A., et al. Capturing the patient's view of change as a clinical outcome measure. JAMA 282 (1999) 1157-1162
31. Guyatt G.H., Norman G.R., Juniper E.F., et al. A critical look at transition ratings. J Clin Epidemiol 55 (2002) 900-908
32. Perkins J.A., and Coltrera M.D. Relational databases for rare disease study: application to vascular anomalies. Arch Otolaryngol Head Neck Surg 134 (2008) 62-66